pulmonary vascular congestion on postural changes in the perfusion and filling of the pulmonary vascular bed. J Clin Attacking the "-neurophysiologic trigger" with drugs has also been reported by Nixon and colleagues in patients.5 They suggested that prophylactic use of sleep therapy (i.e. pethidine plus promethazine) reduces mortality from acute myocardial infarction.
Most methods for finding new antiarrhythmic drugs have been based on the idea that drugs must act directly on myocardial cell membranes to exert an antiarrhythmic effect. The failure of studies on isolated tissues to lead to promising new drugs may be due to the fact that the causative factors of arrhythmias occurring in vivo are missing in these preparations. Based on the data cited above plus the data of Lown and colleagues showing that sleep will suppress ventricular premature beats, we feel that consideration of the nervous system may provide the basic understanding for discovering safe and effective new antiarrhythmic drugs.
RICHARD Perhaps the differences in our data may be explained by differences in duration of drug ingestion. Most patients in Lichtman's paper were studied after only one dose of the drug. The two patients that were on chronic oral therapy, only had measurements while they were on propranolol. No control P50s were done while they were off the drug. 
